Incidence and Outcomes of Out-of-Hospital Cardiac Arrest Patients Admitted to the Hospital in Canada from 2013 to 2017
Nicholas Grubic(Institute for Clinical Evaluative Sciences), Aaron Sibley(University of Prince Edward Island), Judah Goldstein(Nova Scotia Health Authority), Dennis T. Ko(University of Toronto), Katherine S. Allan(St. Michael's Hospital), Jeffrey A. Bakal(University of Alberta), Steve Lin(Brooks Automation (Germany)), Philip J. Davis(University of Saskatchewan), Ian E. Blanchard(Alberta Health Services), Patrick R. Lawler(McGill University Health Centre), Eli Segal(St. Michael's Hospital), Dirk Huyer(University of Toronto), Sharmila Udupa, Brian L. Metcalfe(AWE Nuclear Security Technologies), Allan DeCaen(St. Michael's Hospital), Katie N. Dainty(St. Michael's Hospital), Luc deMontigny, Matthew Bowes, Sean van Diepen(University of Alberta), Manya Charette(American Society of Clinical Oncology), Gerald Lazarenko(St. Michael's Hospital), Martin A. Green(UNSW Sydney), Ehsan Ghamarian(St. Michael's Hospital), Christopher B. Fordyce(Vancouver General Hospital), Gerald Lebovic(St. Michael's Hospital), Jim Christenson(University of British Columbia), Simon P. Avis, John L. Sapp(Queen Elizabeth II Health Sciences Centre), Paul Olszynski(University of Saskatchewan), Kris Cunningham(University of Toronto), Brian Grunau(University of British Columbia), Paul Dorian(St. Michael's Hospital), Alix Carter(Dalhousie University), Sean P. Connors, Jan Jensen, Justin A. Ezekowitz(University of Alberta), Elizabeth Brooks-Lim, Sheldon Cheskes(Cancer Research And Biostatistics)
Cited by 6
Related Papers
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
Canadian Implantable Defibrillator Study (CIDS)
|Circulation|2000|1.6k
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k
Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction
|New England Journal of Medicine|2004|1.5k
American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
|Journal of Clinical Oncology|2004|1.5k